FT News Briefing cover image

The year of weight-loss drugs

FT News Briefing

00:00

Intro

This chapter explores the UK's consideration of cutting interest rates amidst improving economic conditions, especially with decreasing inflation. It also highlights the impact of weight loss drugs like Ozempic and Wegovi, focusing on their significance in both obesity treatment and preventative healthcare, along with the recognition of Novo Nordisk's CEO as Person of the Year.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app